Life Interrupted – Nick’s Fight Against Aplastic Anemia
Person's Name:
Nick Karavite
Here is Nick's story, as told by his mom, Pamela Karavite
Bone Marrow Disease(s):
Content source:
treatment
Danicopan (ACH-4471)
Ivana Gojo, MD
Gojo, Ivana
Professor of Oncology
Johns Hopkins Sidney Kimmel Cancer Center
Dr. Ivana Gojo is a Hematologist/Oncologist in Baltimore.
Online Profile:
Tamibarotene
Tamibarotene (brand name: Amnolake), also called retinobenzoic acid, is orally active, synthetic retinoid, developed to overcome all-trans retinoic acid (ATRA) resistance, with potential antineoplastic activity against acute promyelocytic leukaemia (APL) .
Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
Key Points
In patients with RR-AML, venetoclax combination therapy resulted in responses in 31% of patients and a median OS of 6.1 months.
NPM1 mutations predicted higher response rates; adverse cytogenetics and mutations in TP53, KRAS/NRAS, and SF3B1 predicted worse OS.
Jane Liesveld, MD
Liesveld, Jane
Hematologist
Strong Memorial Hospital
Online Profile:
TP53 Modifier Impresses in Early MDS/AML Study
A drug that targets a common mutation in
Azacitidine Maintenance Fails to Improve Post-Transplant Outcomes in High-Risk AML and MDS
Sandrine Niyongere, MD
Niyongere, Sandrine
Assistant Professor of Medicine
University of Maryland Greenebaum Comprehensive Cancer Center
We Made It! – Kristy Shares her Perspective in January 2021
Person's Name:
Kristy Maliczowski
We made it to another treatment day without anyone in our family getting sick! The week leading to treatment day has become pretty worrisome for me. What if someone in our family gets sick with or is exposed to COVID? Josh will not be able to get his infusion within the treatment window and then what? The questions I never thought I'd have to wonder about.
Bone Marrow Disease(s):
Content source: